Evidence map›Paper›PMID 21219939›Full record

ArticleBehavioural brain research2011

Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics.

Thomas E Wooters, Michael T Bardo, Linda P Dwoskin, Narasimha M Midde, Adrian M Gomez, Charles F Mactutus, Rosemarie M Booze, Jun Zhu

Abstract read
In one paragraph

Article in Behavioural brain research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Environmental enrichment and a selective metabotropic glutamate receptorPharmacology, biochemistry, and behavior · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Environmental enrichment enhances synaptic plasticity by internalization of striatal dopamine transporters.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Thomas E WootersDepartment of Psychology, University of Kentucky, Lexington, KY 40506, USA.
Michael T Bardo
Linda P Dwoskin
Narasimha M Midde
Adrian M Gomez
Charles F Mactutus
Rosemarie M Booze
Jun Zhu
University of Kentucky · USUniversity of South Carolina · US

Funding

HIV/COCAINE NEUROTOXICITY IN FEMALESR01DA013137 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BOOZE, ROSEMARIE M, MACTUTUS, CHARLES F. · 2000 to 2021
$7.7M
NOVELTY, DOPAMINE AND RESPONSE TO AMPHETAMINER01DA012964 · NIDA · YAUPON THERAPEUTICS, INC. · PI BARDO, MICHAEL T · 2000 to 2013
$3.7M
Maternal HIV: Developmental Neurotoxicity - Administrative SupplementR01HD043680 · NICHD · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BOOZE, ROSEMARIE M, MACTUTUS, CHARLES F. · 2003 to 2016
$2.8M
Role of Dopamine Transporter: HIV-1 Tat Protein and Nicotine SensitizationR03DA026721 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI ZHU, JUN · 2009 to 2010
$287k
Role of DARPP-32: Individual Responsiveness to NicotineR03DA024275 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI ZHU, JUN · 2009 to 2010
$144k
Reinforcing and neurochemical effects of cocaine in a rodent model of ADHDF31DA023853 · NIDA · UNIVERSITY OF KENTUCKY · PI WOOTERS, THOMAS E · 2008 to 2009
$59k
NICHD NIH HHS R01 HD043680NIDA NIH HHS DA012964NIDA NIH HHS DA013137NIDA NIH HHS DA023853NIDA NIH HHS DA024275NIDA NIH HHS DA026721NIDA NIH HHS F31 DA023853NIDA NIH HHS R01 DA012964NIDA NIH HHS R01 DA013137NIDA NIH HHS R03 DA024275NIDA NIH HHS R03 DA026721
6 · The paper itself

Abstract

Rats raised in an enriched condition (EC) are less sensitive to the locomotor effects of stimulant drugs than rats raised in an impoverished condition (IC). Methylphenidate (MPD), a primary pharmacotherapy for attention-deficit/hyperactivity disorder, has abuse potential. This study determined whether environmental enrichment differentially altered the effects of MPD on locomotor activity and dopamine (DA) transporter (DAT) function. Acute and repeated MPD (3 or 10 mg/kg, s.c.) increased locomotion in EC, IC and social condition (SC) rats; however, EC rats showed a blunted response to repeated MPD (3 mg/kg). The maximal velocity (V(max)) of [(3)H]DA uptake in the presence of the combination of phorbol 12-myristate 13-acetate, a protein kinase C (PKC) activator and okadaic acid, a protein phosphatase inhibitor was decreased in EC and IC rats by 68% and 40%, respectively, indicating that DAT in prefrontal cortex (PFC) is more sensitive to PKC-mediated down-regulation in EC rats. Acute MPD (10 mg/kg) administration decreased the V(max) of [(3)H]DA uptake in PFC and striatum in EC rats, but not in IC rats. Furthermore, [(3)H]WIN 35,428 binding density was decreased in PFC of EC and IC rats, and in striatum of EC rats given repeated MPD (10 mg/kg). These results demonstrate that environmental enrichment modulates DAT dynamics in PFC. However, since the change in DAT function was observed only following the high dose of MPH (10 mg/kg), the attenuated locomotor response to repeated MPD (3 mg/kg) in EC rats is not likely due to a specific DAT alteration in the brain regions examined.

Indexed as

EnvironmentAnimalsBehavior, AnimalCentral Nervous System StimulantsCocaineDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsMaleMethylphenidateMotor ActivityPrefrontal CortexRatsRats, Sprague-Dawley(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl esterCentral Nervous System StimulantsCocaineDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsMethylphenidate

Identifiers

PMID21219939
PMCPMC3062741
OpenAlexW2133711068

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.